title: Intraductal injection of LPS as a mouse model of mastitis: signaling visualized via an NF-κB reporter transgenic.
abstract: Animal models of human disease are necessary in order to rigorously study stages of disease progression and associated mechanisms, and ultimately, as pre-clinical models to test interventions. In these methods, we describe a technique in which lipopolysaccharide (LPS) is injected into the lactating mouse mammary gland via the nipple, effectively modeling mastitis, or inflammation, of the gland. This simulated infection results in increased nuclear factor kappa B (NF-κB) signaling, as visualized through bioluminescent imaging of an NF-κB luciferase reporter mouse. Our ultimate goal in developing these methods was to study the inflammation associated with mastitis in the lactating gland, which often includes redness, swelling, and immune cell infiltration. Therefore, we were keenly aware that incision or any type of wounding of the skin, the nipple, or the gland in order to introduce the LPS could not be utilized in our methods since the approach would likely confound the read-out of inflammation. We also desired a straight-forward method that did not require specially made hand-drawn pipettes or the use of micromanipulators to hold these specialized tools in place. Thus, we determined to use a commercially available insulin syringe and to inject the agent into the mammary duct of an intact nipple. This method was successful and allowed us to study the inflammation associated with LPS injection without any additional effects overlaid by the process of injection. In addition, this method also utilized an NF-κB luciferase reporter transgenic mouse and bioluminescent imaging technology to visually and quantitatively show increased NF-κB signaling within the LPS-injected gland. These methods are of interest to researchers of many disciplines who wish to model disease within the lactating mammary gland, as ultimately, the technique described here could be utilized for injection of a number of substances, and is not limited to only LPS.
authors.affiliation: Cancer Biology Department, Vanderbilt University Medical Center, USA.
authors.forename: Whitney
authors.initials: W
authors.lastname: Barham
authors.forename: Taylor
authors.initials: T
authors.lastname: Sherrill
authors.forename: Linda
authors.initials: L
authors.lastname: Connelly
authors.forename: Timothy S
authors.initials: TS
authors.lastname: Blackwell
authors.forename: Fiona E
authors.initials: FE
authors.lastname: Yull
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D005260:Female; D017930:Genes, Reporter; D008070:Lipopolysaccharides / Q000008:administration & dosage*; D008413:Mastitis / Q000139:chemically induced* / Q000235:genetics* / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D016328:NF-kappa B / Q000235:genetics* / Q000378:metabolism; D015398:Signal Transduction
chemical_list: D008070:Lipopolysaccharides; D016328:NF-kappa B